Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSC-30 |
Human glioma stem-like cells | Human | brain | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Nabissi et al., Int. J. Cancer, 2015, 137: 1855-1869 | Link | ||
GSC-83 |
Human glioma stem-like cells | Human | brain | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Nabissi et al., Int. J. Cancer, 2015, 137: 1855-1869 | Link | ||
GSC-83 |
Human glioblastoma stem-like cells | Human | brain | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. B. Morelli et al., Int. J. of Cancer, 2012, 131: E1067–E1077, DOI: 10.1002/ijc.27588 | Link | ||
hASMC |
Human arterial smooth muscle cells | Human | vasculature | unknown | siRNA | RNA-Interference | Metafectene SI | publication | M. R. Schroeter et al., Cardiovasc Res, Aug 2013; 99: 555 - 565 | Link | |||
hBCSCs |
Human breast cancer stem cells (from xenografts of human breast cancers) | Human | respiratory system | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | W.-W. Chang et al., Breast Cancer Res., 2013, 15: R39, doi:10.1186/bcr3423 | Link | ||
HCT-116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | N. Golob-Schwarzl et al., Oncotarget, 2017, 8(60): 101224-101243 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | Q. Zhang et al., eLife Sci, Jan 2014; 3: e03077 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | O. D. K. Maddocks et al., Natur, 2013, 542 (493), doi:10.1038/nature11743 | ||
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | X. Zhou et al., Cell Death and Differentiation, 2015, 22:755-766; doi:10.1038/cdd.2014.167 | Link | |
HCT116 |
Human colon carcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | S. Belluti et al., Cell Death and Disease (2013) 4, e756; doi:10.1038/cddis.2013.287 | ||
HCT116 p53 -/- |
Human colon adenocarcinoma cell line deficient of p53 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | X. Zhou et al., J. Biol. Chem., Jul 2013; 288: 21793 - 21801 | Link | ||
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | D. A. Eisinger et al., Mol. Pharmacol., Feb 2011; 79: 326 - 335 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | S. M. Usmani et al., Cell. Microbiology, 2012, 14(3): 299–315, doi:10.1111/j.1462-5822.2011.01724.x | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. M. Giudetti et al., BBA, 2020, 1865, doi.org/10.1016/j.bbalip.2020.158805 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | application note | ![]() |
||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | application note | ![]() |
||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | application note | ![]() |
||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | R. Romano et al., Cell. and Mol. Life Sci., 2021, 78: 351–372, 78:351–372, doi.org/10.1007/s00018-020-03510-1 | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. Prokesch et al., FASEB J., 2017, 31: 732-742 | Link | |
hOMs |
Human primary olfactory mucosal cells | Human | sensory organs | primary cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | S. Chew et al., Chew et al. Particle and Fibre Toxicology , 2020, 17: 18, doi.org/10.1186/s12989-020-00352-4 | Link | ||
Hs888 |
Human osteosarcoma cell line | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | V. R. L. Vasco et al., J. Cell Commun. Signal, 2014, 8:219-229, DOI 10.1007/s12079-014-0235-9 | Link | ||
Hs888 |
Human osteosarcoma cell line | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Leopizzi., PhD Thesis, 2018, University of Rome | Link | ||
Hs888 |
Human osteosarcoma cell line | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | V. R. Lo Vasco et al., Anticancer Res, Aug 2014; 34: 4069 - 4075 | |||
Hs888 |
Human osteosarcoma cell line | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | V. R. Lo Vasco et al., J. Cell Commun. Signal., 2015, 9:55-62; DOI 10.1007/s12079-015-0265-y | |||
HT-29 |
Human colorectal adenocarcinoma cell line | ATCC HTB-38 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | N. Golob-Schwarzl et al., Oncotarget, 2017, 8(60): 101224-101243 | Link |